Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P D COOPER

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
Hospital Trustee|June 11, 1979
Health care marketing managementP D Cooper
Pharmaceutical Biotechnology|January 1, 1995
Vaccine adjuvants based on gamma inulinP D Cooper
Advances in Immunity and Cancer Therapy|January 1, 1985
Complement and cancer: activation of the alternative pathway as a theoretical base for immunotherapyP D Cooper
The Journal of General Virology|November 1, 1975
Relations between poliovirus polypeptides as shown by tryptic peptide analysisG Abraham, P D Cooper
Molecular Immunology|August 1, 1986
Anti-complementary action of polymorphic "solubility forms" of particulate inulinP D Cooper, M Carter
Molecular Immunology|August 1, 1986
The anti-melanoma activity of inulin in miceP D Cooper, M Carter
The Journal of General Virology|November 1, 1975
Poliovirus polypeptides examined in more detailG Abraham, P D Cooper
British Journal of Cancer|December 6, 2006
Potentiation of photodynamic therapy of cancer by complement: the effect of gamma-inulinM Korbelik, P D Cooper
Vaccine|May 1, 1991
Algammulin, a new vaccine adjuvant comprising gamma inulin particles containing alum: preparation and in vitro propertiesP D Cooper, E J Steele
International Journal of Cancer|May 15, 1984
Substances that can trigger activation of the alternative pathway of complement have anti-melanoma activity in miceP D Cooper, R B Sim
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Hospital Trustee|June 11, 1979
Health care marketing managementP D Cooper
Pharmaceutical Biotechnology|January 1, 1995
Vaccine adjuvants based on gamma inulinP D Cooper
Advances in Immunity and Cancer Therapy|January 1, 1985
Complement and cancer: activation of the alternative pathway as a theoretical base for immunotherapyP D Cooper
The Journal of General Virology|November 1, 1975
Relations between poliovirus polypeptides as shown by tryptic peptide analysisG Abraham, P D Cooper
Molecular Immunology|August 1, 1986
Anti-complementary action of polymorphic "solubility forms" of particulate inulinP D Cooper, M Carter
Molecular Immunology|August 1, 1986
The anti-melanoma activity of inulin in miceP D Cooper, M Carter
The Journal of General Virology|November 1, 1975
Poliovirus polypeptides examined in more detailG Abraham, P D Cooper
British Journal of Cancer|December 6, 2006
Potentiation of photodynamic therapy of cancer by complement: the effect of gamma-inulinM Korbelik, P D Cooper
Vaccine|May 1, 1991
Algammulin, a new vaccine adjuvant comprising gamma inulin particles containing alum: preparation and in vitro propertiesP D Cooper, E J Steele
International Journal of Cancer|May 15, 1984
Substances that can trigger activation of the alternative pathway of complement have anti-melanoma activity in miceP D Cooper, R B Sim
Pageof 5